image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Scapa - Another upgrade sends shares over £2

July 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SCPA
  • Price:
  • 194p
Amazingly, Scapa’s full year results have again beaten forecasts despite three upgrades last year and the shares have soared above £2.For the year ended 31 March revenues, pretax profit and eps grew 4%, 22% and 26% respectively to £236m, £13.7m and 9.1p. Although that was £8.8m worse than a year ago it included the £11m acquisition of First Water.Healthcare, which supplies advanced woundcare products and medical tapes, such as disposable adhesive pads for medical devices, increased sales 8% to £373.8m while profits rose 9% to £11.1m, with margins up 0.3% to 15%.  Visibility is benefiting from significant multi-year outsourcing contracts with major blue chip companies. In ad ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X